top of page

Search


KÄÄPÄ Biotech Maps Chaga Evidence to Ageing Biomarkers in New White Paper
Too long to read? KÄÄPÄ Biotech and MycoStories have published Beyond Skin Deep, a white paper that maps the evidence on Chaga (Inonotus obliquus) against the twelve Hallmarks of Ageing and finds the current evidence base touches nine of them. The framework shifts functional mushroom positioning away from surface claims such as skin appearance and energy towards measurable, hallmark-level biomarkers, anchored by an acute human trial of KÄÄPÄ's standardised NordRelease® Chaga
3 days ago


John Innes Centre Engineers Wheat Immune Receptor to Tackle Blast Fungus Crop Disease
Scientists at the John Innes Centre, working with Kobe University, have engineered a plant immune receptor that detects effector proteins from two different strains of blast fungus at once, as reported in Science Advances.
The team mapped how receptor decoy domains bind fungal effectors using X-ray crystallography, then used that map to modify the receptor, and tested it in wheat protoplasts (wheat cells with their walls removed).
5 days ago


MUSHEEZ® Brings Mushroom Research to the Menu
A research-inspired recipe book, new food and beverage opportunities and an exclusive BIOVIT™ distribution agreement highlight the Estonian supplier’s latest developments. Article written in partnership with MUSHEEZ®. Too long to read? Estonian functional mushroom extract supplier MUSHEEZ® has published Functional Mushrooms on the Menu, a book of 17 food and drink ideas, each built on a published study, ahead of Fi Europe in Frankfurt on 17–19 November 2026. Each concept sets
Nov 6


Building Intellectual Property within Fungal Biotechnology: Where Fungi fit in U.S. IP Law
A patent provides a limited period of market exclusivity to the owner of a new, useful and nonobvious invention, in exchange for public disclosure of the invention. The inventor explains how to make and use the invention, and the owner gains the right to exclude others from making, using, selling, offering to sell or importing the claimed invention. Following an intensive examination at the U.S. Patent and Trademark Office (USPTO), enforceable patent claims issue and generall
Nov 5


Mycofeast Acquires New Zealand's Daisy Lab to Scale Precision-Fermented Lactoferrin
UK fermentation firm Mycofeast has acquired Daisy Lab, a New Zealand startup that makes cow-free whey proteins, of which bovine lactoferrin is the most advanced.
Daisy Lab uses precision fermentation, which inserts specific DNA into microbes so they produce a target protein, and has installed a 500-litre fermenter for scale-up.
Nov 2
bottom of page
